Omrix Biopharmaceuticals Ltd., a prominent player in the biopharmaceutical industry, is headquartered in Israel (IL) and operates extensively in various global markets. Founded in 2000, the company has established itself as a leader in the development and manufacturing of innovative therapeutic solutions, particularly in the fields of immunology and oncology. Omrix is renowned for its unique core products, including advanced biologics and biosimilars, which are designed to address critical medical needs. The company’s commitment to quality and innovation has positioned it favourably within the competitive landscape, earning recognition for its contributions to patient care. With a focus on research and development, Omrix continues to achieve significant milestones, solidifying its reputation as a trusted name in biopharmaceuticals.
We don't have data for Omrix Biopharmaceuticals Ltd., but we can show you information about their parent organization instead.
View parent company